- Clinical Research
- Sell Sheet
Patrick Burgess, MD: Hypoglycemia and Impact of Late Glucose Checks
Patrick Burgess, MD, PhD, founder and inventor of EndoTool, sat down with MD Magazine® to discuss his study on the impact of late glucose checks as well as other important topics being covered at the American Diabetes Association’s 79th Scientific Sessions.
Impact of Late Glucose Checks on Hypoglycemia Incidence
Download the retrospective study presented at the American Diabetes Association’s 79th Scientific Sessions to learn more about the impact of blood glucose check timing on hypoglycemia incidence for intravenous insulin therapy.
How Technology Can Support Adoption of Best Practices for Inpatient and Outpatient Insulin Management
In this on demand webinar, Dr. Mark Vanderwel and Amy Butts, PA-C, MPAS, CDE, BC-ADM discuss the current challenges in initiating insulin therapy, review the best practices, and discuss how technology can be used and implemented to benefit both patients and providers.
Measure of Safety for Q2Hour Vs. Q1Hour Glucose Checks for Intravenous Insulin Dosing
Download the AACE 2019 Poster to see how you can save time and money and improve patient care with EndoTool Q2Hour insulin dosing.
Goal Range Effect On Hypoglycemia Incidence for Intravenous Insulin Dosing
Download the AACE 2019 poster to learn more about the effect of the blood glucose goal range on the incidence of hypoglycemia for intravenous insulin dosing.
Breaking the Barriers of Inpatient Glycemic Management Quality Improvement
In an on-demand webinar, Dr. Sandy Fogel from Carilion Clinic will discusses the steps to quality improvement for inpatient glycemic management and the impact it has on both clinical and financial outcomes.
How EndoTool IV Supports Post-Operative Glycemic Management
Dr. Sandy Fogel of Carilion Clinic discusses the use of EndoTool IV for post-operative glycemic management.
Glucose Management Technologies for the Critically Ill
In the Journal of Diabetes Science and Technology article, the authors discuss the current technology products for glycemic care in the intensive care unit (ICU).